Organisation paid for research Program year 2025 Source: CMS Open Payments

Clinnova Rsrch Solutions Corp.

Neither a doctor nor a teaching hospital

Research payments

$348,937

168 payments

Through program year 2025, Clinnova Rsrch Solutions Corp. is reported as receiving $348,937 in research payments, across 168 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$54,520	50
2024	Research	$87,799	43
2023	Research	$182,475	65
2022	Research	$24,143	10

Breakdown

Who paid Research payments · program years 2022–2025

Janssen Research & Development, LLC $348,937 168 payments

Studies the money was for Research payments · program years 2022–2025

A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease $175,476 80 payments
Cnto1959crd3004 $139,103 65 payments
67953964Mdd3004 $15,100 10 payments
A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) (VENTURA-RWE) $10,725 6 payments
A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease (GRAVITI) $8,533 7 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.